Authors: Szalai, C.; Buzas, E. I.; Fulop, A. K.; Kohidai, L.; Falus, A.

Source: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Cu, Volume 5, Number 4, November 2006 , pp. 383-399(17)

Publisher: Bentham Science Publishers

Abstract:

Pharmacogenomics, a fascinating, emerging area of biomedical research is strongly influenced by growing availability of genomic databases, high-through-put genomic technologies, bioinformatic tools and artificial computational modeling approaches. Multinational clusters, such as the regional and internet-driven pharmaco-grids generated an entirely new environment for research and development in pharmacology. Although the field of pharmacogenomics is in its infancy, the promise of pharmacogenomics lies in its potential to predict genomic sources of interindividual variability in drug response (both efficacy and toxicity), thus allowing individualization of therapy to maximize effectiveness and minimize risk. Thus, pharmacogenomics holds the promise for individualized medicine adapted to each person's own genetic makeup. Environmental factors including diet, age, and lifestyle as well as infection can influence a person's response to medicines, but understanding an individual's genetic background is thought to be the key to creating personalized drugs with greater efficacy and safety. Similar to other biomedical fields, in allergic and autoimmune diseases pharmacogenomics combines traditional pharmaceutical sciences such as biochemistry with annotated knowledge of genes, proteins, and single nucleotide polymorphisms (SNP). One of the major challenges now are developing and applying the statistical and computational capacity to store, manage, analyze and interpret the wealth of data being generated. This review summarizes the recent pharmacogenomic trends in inflammatory diseases with particular attention to autoimmune conditions and asthma.

Keywords: Pharmacogenomics; asthma; autoimmunity; single nucleotide polymorphism

Document Type: Research article

DOI: http://dx.doi.org/10.2174/187152306778772847

Affiliations: 1: Department of Genetics, Cell- and Immunobiology, Semmelweis University, 1089 Budapest, Nagyvaradter 4., Hungary.

Publication date: 2006-11-01

More about this publication?

• Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Anti-Inflammatory & Anti-Allergy Agents.
  
  Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Anti-Inflammatory & Anti-Allergy Medicinal Chemistry.
  
  Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Anti-Inflammatory & Anti-Allergy Agents drug discovery.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Szalai, C. ;  Buzas, E. I. ;  Fulop, A. K. ;  Kohidai, L. ;  Falus, A.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers